Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Private Placement: Ready for a Golden Opportunity in Ghana and Canada? (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ATAI Life Sciences NV
ATAI
Healthcare
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B...
receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ATAI)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
StockJunkie4994
X
Post by
StockJunkie4994
on May 08, 2023 11:49am
Top 5 Shroom Stocks
https://thedalesreport.com/psychedelics/tdrs-top-5-psychedelic-developments-for-the-week-of-may-1/
(0)
•••
Karylle
X
Post by
Karylle
on Apr 13, 2023 4:10am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
Datametrex AI Launches AnalyticsGPT
posted Sep 24, 2023 9:00am by
Datametrex AI Ltd
-
|
The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. In the following weeks, Datametrex will be announcing additional packages and pricing models designed to allow smaller businesses to leverage the power of ...read more
(0)
•••
Karylle
X
Post by
Karylle
on Jul 15, 2022 9:45pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
Karylle
X
Post by
Karylle
on Jun 03, 2022 5:29am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of
...more
(0)
•••
Karylle
X
Post by
Karylle
on Jun 02, 2022 12:39am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
Karylle
X
Post by
Karylle
on May 11, 2022 1:53am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
Karylle
X
Post by
Karylle
on May 03, 2022 1:41am
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
Karylle
X
Post by
Karylle
on Apr 25, 2022 2:33am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(0)
•••
Karylle
X
Post by
Karylle
on Apr 18, 2022 2:40am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
Karylle
X
Post by
Karylle
on Apr 09, 2022 12:55pm
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
Karylle
X
Post by
Karylle
on Apr 07, 2022 1:05pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(433)
•••
AwareInvestor
X
Post by
AwareInvestor
on Jun 18, 2021 7:54am
Atai Life Sciences Increases IPO To $225 Million
Atai Life Sciences late last night announced the pricing of its upsized initial public offering. The clinical-stage biotech firm now expects its IPO to raise gross proceeds of roughly $225.0 million
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nickel Miner Announces a Battery Supply Chain MOU with “PPES”, a JV Between Toyota and Panasonic
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Criminal syndicate allegedly infiltrated Barrick Gold subsidiary